ODTX Odyssey Therapeutics, Inc.
$18.34
Odyssey Therapeutics, Inc. (ODTX) is expected to report earnings on February 3, 2027, before the market open. The consensus earnings estimate is a loss of $1.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -16.2% since its last earnings release on November 4, 2026.
Odyssey Therapeutics Beat Consensus Estimates
Wednesday, November 4, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 7:00 AM ET
Earnings Whisper
-
vs ($1.14)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$19.35
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
Sector
Healthcare
Industry
Biotechnology
Charts powered in part by Lightweight Charts™ by TradingView.